LONDON -- -- Severe acute respiratory syndrome (SARS) cannot be contracted from handling letters or postal packages sent from the world's affected regions.
Chronopost International Air Express, which is the global express parcel service of United Kingdom-based parcel couriers, Parceline and Interlink Express, commissioned independent medical advice to reassure its customers and employees.
Professor Francios Bricaire, head of infectious diseases at La Pitie-Salpetriere Hospital in Paris, was specifically asked about the risk of getting infected by the virus from paper or cardboard.
"Fortunately this virus is much too fragile to survive more than a few hours on inert materials and so there is no risk of infection from handling a letter or postal package from the infected areas," Bricaire said. "People handling such packages need take no special precautions."
Bricaire described the symptoms of the illness as a temperature over 38 degrees Centigrade with coughing and shortness of breath. He said people who do not have these symptoms cannot transmit the virus.
Nigel Brett of Chronopost International said, "We take our responsibility to our customers and employees very seriously and felt it was our duty to seek expert medical advice to reassure them."
Chronopost International delivers air express parcels and documents to 220 countries worldwide.
The first cases of SARS appeared in China's Canton province. It is a viral infection affecting the respiratory system. It is produced by a known species of virus whose effects are benign although little research has been conducted on it. It is considered to have evolved into a more serious version that can cause acute respiratory difficulties and even death. It is transmitted by close contact with those suffering from the illness and surgical masks must be worn.
Source: Parceline and Interlink Express
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.